Management of osteoporosis: the Indian perspective.

Rohini Handa

Journal: Clinical calcium 2005;14(9):100-5

PMID: 15577120

Abstract

Osteoporosis is a common but neglected problem in India. The major challenges to management are lack of awareness and resource constraints. The management is also hampered by the non-availability of normative data for bone mineral density in Indians. Subclinical vitamin D deficiency is widespread. The drugs available in the country include calcium, vitamin D, hormone replacement therapy, raloxifene, alendronate, risedronate, calcitonin and teriparatide. Bisphosphonates (alendronate) constitute the mainstay of treatment in India. There is a need for evidence based, context specific and resource sensitive guidelines.

Address: Osteporosis Society of India, All India Institute of Medical Sciences, New Delhi, India.

Link outs

Free resources

Medical:

https://medlineplus.gov/osteoporosis.html

MeSH Terms: Age Factors, Alendronate, Bone Density, Calcium, Dietary, Female, Humans, India, Life Style, Male, National Health Programs, Osteoporosis, Patient Education as Topic, Tuberculosis, Spinal, Vitamin D Deficiency